DRAGON PHARMACEUTICAL INC 4
4 · DRAGON PHARMACEUTICAL INC · Filed Oct 4, 2005
Insider Transaction Report
Form 4
Han Yanlin
DirectorChief Executive Officer
Transactions
- Award
Options
2005-09-30+500,000→ 500,000 totalExercise: $0.74From: 2005-09-30Exp: 2010-09-30→ Common (500,000 underlying)
Footnotes (1)
- [F1]Includes stock options only. Does not include 2,997,682 "Additional Closing Dragon Shares" which have already been reported. Under the terms of the June 11, 2004 Share Purchase Agreement, Mr. Han received Additional Closing Dragon Shares in order to maintain his pro rata interest in the Company in the event certain options and warrants outstanding as of the closing date are subsequently exercised. The Additional Closing Dragon Shares may be issued or cancelled depending on whether or not such outstanding options or warrants are exercised or cancelled. Such Additional Closing Dragon Shares are held in escrow and are not assumed outstanding until released from escrow.